The Development of an Immunohistochemical Method to Detect the Autophagy-Associated Protein LC3-II in Human Tumor Xenografts
Sarah V. Holt(Pharma Nord (United Kingdom)), Robert W. Wilkinson(Immunocore (United Kingdom)), Beata S. Wyspiańska(AstraZeneca (United Kingdom)), Dominic I. James(AstraZeneca (United Kingdom)), John R. Foster(Boston University), Kevin J. Randall(Medicines Discovery Catapult)
Cited by 53
Related Papers
Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression
|Journal of Cell Science|2004|344
The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
|British Journal of Cancer|2012|111
MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue
|British Journal of Cancer|2017|110
Silencing Cenp-F weakens centromeric cohesion, prevents chromosome alignment and activates the spindle checkpoint
|Journal of Cell Science|2005|108